Coherus Oncology Inc. (chrs 1.5 04/15/26)
13F holders, Q2 2024 (June 30)3holders
0new positions
0sold out
$0.73avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding Coherus Oncology Inc. (chrs 1.5 04/15/26) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Jane Street Group, LLC ($2.2M), Avantax Advisory Services, Inc. ($7K) and Northwestern Mutual Wealth Management Co. ($4K).
- Company
- Coherus Oncology Inc. (chrs 1.5 04/15/26)
- CUSIP
- 19249HAB9
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 3 holders
| Jane Street Group, LLC | 0.00% | No change | 3,000,000 | $2.2M |
| Avantax Advisory Services, Inc. | 0.00% | No change | 10,000 | $7K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 6,000 | $4K |
"% of holder's portfolio" is COHERUS ONCOLOGY INC (CHRS 1.5 04/15/26)'s weight in each manager's 13F, not the share of Coherus Oncology Inc. (chrs 1.5 04/15/26) the manager owns.